
Tenax Therapeutics Inc
NASDAQ:TENX

Fundamental Analysis


Revenue & Expenses Breakdown
Tenax Therapeutics Inc
Balance Sheet Decomposition
Tenax Therapeutics Inc
Current Assets | 96.7m |
Cash & Short-Term Investments | 94.9m |
Other Current Assets | 1.8m |
Free Cash Flow Analysis
Tenax Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Tenax Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-19.5m
USD
|
Operating Income
|
-19.5m
USD
|
Other Expenses
|
1.9m
USD
|
Net Income
|
-17.6m
USD
|
TENX Profitability Score
Profitability Due Diligence
Tenax Therapeutics Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Score
Tenax Therapeutics Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
TENX Solvency Score
Solvency Due Diligence
Tenax Therapeutics Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Score
Tenax Therapeutics Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TENX Price Targets Summary
Tenax Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
TENX
is 22.44 USD
with a low forecast of 16.16 USD and a high forecast of 31.5 USD.
Dividends
Current shareholder yield for TENX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?